Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Search by expertise, name or affiliation
Nuclear factor-κB, cancer, and apoptosis
Vincent Bours
*
, Mohamed Bentires-Alj
, Anne Cécile Hellin
, Patrick Viatour
, Pierre Robe
,
Sylvie Delhalle
, Valérie Benoit
, Marie Paule Merville
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
213
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nuclear factor-κB, cancer, and apoptosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Malignant Neoplasm
100%
Programmed Cell Death
100%
Nuclear Factor
100%
Alternative Complement Pathway C3 C5 Convertase
100%
Cancer Cell
16%
Antiapoptotic
16%
B Lymphocyte
8%
Cancer Treatment
8%
Breast Cancer
8%
Cancer Therapy
8%
Ionizing Radiation
8%
Gene Expression
8%
Cancer Cell Line
8%
Tumor Necrosis Factor
8%
Antiinfective Agent
8%
Hodgkin's Lymphoma
8%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Nuclear Factor
100%
Alternative Complement Pathway C3 C5 Convertase
100%
Antiapoptotic
16%
Chemotherapy
8%
Ionizing Radiation
8%
Breast Cancer
8%
Antiinfective Agent
8%
Tumor Necrosis Factor
8%
Hodgkin Disease
8%
Biochemistry, Genetics and Molecular Biology
Complement Factor B
100%
Programmed Cell Death
100%
Cancer Cell
25%
Genetics
8%
Anticancer
8%
Gene Expression
8%
B Cell
8%
Tumor Necrosis Factor
8%
Immunology and Microbiology
Complement Factor B
100%
Programmed Cell Death
100%
Cancer Cell
16%
B Cell
8%
Tumor Necrosis Factor
8%
Cancer Cell Line
8%
Gene Expression
8%
Keyphrases
Signal-dependent
8%
Cell Mortality
8%